Glutamate carboxypeptidase II levels in rodent brain using [ 125I]DCIT quantitative autoradiography

Neuroscience Letters

Volumn 387, Issue 3, 2005, Pages 141-144

  Guilarte, Tomás R ^a   McGlothan, Jennifer L ^a   Foss, Catherine A ^b   Zhou, Jia ^c   Heston, Warren D ^d   Kozikowski, Alan P ^c,e   Pomper, Martin G ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Acenta Discovery   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Glutamate carboxypeptidase II (GCPII NAALADase) levels; Quantitative autoradiography; Rodent brain

Indexed keywords

GLUTAMATE CARBOXYPEPTIDASE II; N [N (1,3 DICARBOXYPROPYL)CARBAMOYL] 3 IODOTYROSINE I 125; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; GENE DOSAGE; ISOTOPE LABELING; KNOCKOUT MOUSE; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOASSAY; RADIOISOTOPE DISTRIBUTION; RAT; RODENT; VALIDATION PROCESS; WILD TYPE;

ANIMALS; BINDING, COMPETITIVE; BIOLOGICAL MARKERS; BRAIN; CARBAMATES; DIAGNOSTIC IMAGING; DIPEPTIDES; ENZYME INHIBITORS; GENE DOSAGE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTAMATE CARBOXYPEPTIDASE II; IODINE RADIOISOTOPES; MICE; MICE, KNOCKOUT; RADIOLIGAND ASSAY; RADIOPHARMACEUTICALS; RATS; RATS, LONG-EVANS; TYROSINE;

EID: 23844507556     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.06.015     Document Type: Article

References (19)

1. D.J. Bacich, E. Ramadan, D.S. O'Keefe, N. Bukhari, I. Wegorzewska, O. Ojeifo, R. Olszewski, C.C. Wrenn, T. Bzdega, B. Wroblewska, W.D. Heston, and J.H. Neale Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate J. Neurochem. 83 2002 20 29
2. U.V. Berger, R. Luthi-Carter, L.A. Passani, S. Elkabes, I. Black, C. Konradi, and J.T. Coyle Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system J. Comp. Neurol. 415 1999 52 64
3. J.T. Coyle The nagging question of the function of N- acetylaspartylglutamate Neurobiol. Dis. 4 1997 231 238
4. C.A. Foss, R.C. Mease, H. Fan, Y. Wang, H.T. Ravert, R.F. Dannals, R.T. Olszewski, W.D. Heston, A.P. Kozikowski, and M.G. Pomper Radiolabeled small molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer Clin. Cancer Res. 11 2005 4022 4028
5. P.J. Fraker, and J.C. Speck Jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a- diphrenylglycoluril Biochem. Biophys. Res. Commun. 80 1978 849 857
6. S. Fuhrman, M. Palkovits, M. Cassidy, and J.H. Neale The regional distribution of N-acetylaspartylglutamate (NAAG) and peptidase activity against NAAG in the rat nervous system J. Neurochem. 62 1994 275 281
7. G.D. Ghadge, B.S. Slusher, A. Bodner, M.D. Canto, K. Wozniak, A.G. Thomas, C. Rojas, T. Tsukamoto, P. Majer, R.J. Miller, A.L. Monti, and R.P. Roos Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models Proc. Natl. Acad. Sci. U.S.A. 100 2003 9554 9559
8. S. Ghose, C.S. Weickert, S.M. Colvin, J.T. Coyle, M.M. Herman, T.M. Hyde, and J.E. Kleinman Glutamate carboxypeptidase II gene expression in the human frontal and temporal lobe in schizophrenia Neuropsychopharmacology 29 2004 117 125
9. P.F. Jackson, D.C. Cole, B.S. Slusher, S.L. Stetz, L.E. Ross, B.A. Donzanti, and D.A. Trainor Design, synthesis and biological activity of a potent inhibitor of the neuropeptidase N-acetylated alpha-linked acidic dipeptidase J. Med. Chem. 39 1996 619 622
10. A.P. Kozikowski, F. Nan, P. Conti, J. Zhang, E. Ramadan, T. Bzdega, B. Wroblewska, J.H. Neale, S. Pshenichkin, and J.T. Wroblewski Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase) J. Med. Chem. 44 2001 298 301
11. A.P. Kozikowski, J. Zhang, F. Nan, P.A. Petukhov, E. Grajkowska, J.T. Wroblewski, T. Yamamoto, T. Bzdega, B. Wroblewska, and J.H. Neale Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents J. Med. Chem. 47 2004 1729 1738
12. R. Luthi-Carter, A.K. Barczak, H. Speno, and J.T. Coyle Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase) J. Pharmacol. Exp. Ther. 286 1998 1020 1025
13. R.T. Olszewski, N. Bukhari, J. Zhou, A.P. Kozikowski, J.T. Wroblewski, S. Shamimi-Noori, B. Wroblewska, T. Bzdega, S. Vicini, F.B. Barton, and J.H. Neale NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR J. Neurochem. 89 2004 876 885
14. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1982 Academic Press
15. C.W. Tiffany, N.S. Cai, C. Rojas, and B.S. Slusher Binding of the glutamate carboxypeptidase II (NAALADase) inhibitor 2-PMPA to rat brain membranes Eur. J. Pharmacol. 427 2001 91 96
16. G. Tsai, G. Forloni, M.B. Robinson, B.L. Stauch, and J.T. Coyle Calcium-dependent evoked release of N-[3H]acetylaspartylglutamate from the optic pathway J. Neurochem. 51 1988 1956 1959
17. G. Tsai, L.A. Passani, B.S. Slusher, R. Carter, L. Baer, J.E. Kleinman, and J.T. Coyle Abnormal excitatory neurotransmitter metabolism in schizophrenic brains Arch. Gen. Psychiatry 52 1995 829 836
18. H.M. Valivullah, J. Lancaster, P.M. Sweetnam, and J.H. Neale Interactions between N-acetylaspartylglutamate and AMPA, kainate, and NMDA binding sites J. Neurochem. 63 1994 1714 1719
19. T. Yamamoto, S. Hirasawa, B. Wroblewska, E. Grajkowska, J. Zhou, A. Kozikowski, J. Wroblewski, and J.H. Neale Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model Eur. J. Neurosci. 20 2004 483 494